Valorisations sectorielles Neurocrine Biosciences, Inc.
Actions
NBIX
US64125C1099
Produits pharmaceutiques
|
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
| 161,50 USD | -2,75 % |
|
-11,67 % | +13,87 % |
| 31/07 | NEUROCRINE BIOSCIENCES, INC. : RBC Capital Markets réitère son opinion positive sur le titre | ZM |
| 31/07 | NEUROCRINE BIOSCIENCES, INC. : Deutsche Bank Securities n'est pas inspiré par le dossier | ZM |
Principaux concurrents
Ajouter à une liste 0 sélectionné | PER (N) | Price to Book (N) | PEG (N) | VE / CA (N) | VE / EBITDA (N) | VE / EBIT (N) | Rendement du dividende (N) | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|
 | 23.67x | 4.29x | 0.47x | 3.92x | 15.16x | 17.19x | -.--% | 16,88 Md | |
| 34.02x | 20.24x | 0.79x | 11.84x | 24.88x | 25.86x | 0,61 % | 995 Md | |
| 28.36x | 6.88x | -1.53x | 6.26x | 17.51x | 19.57x | 2,11 % | 614 Md | |
| 31.72x | 886.55x | 0.14x | 7.19x | 14.9x | 15.26x | 2,84 % | 431 Md | |
| 19.93x | 7.13x | 1.68x | 4.73x | 11.72x | 13x | 2,79 % | 353 Md | |
| 21.85x | 6.15x | -9.53x | 5.66x | 14.11x | 14.95x | 2,84 % | 293 Md | |
| 20.2x | 4.54x | 1.04x | 4.19x | 11.86x | 12.58x | 2,11 % | 245 Md | |
| 25.61x | 19.68x | 3.65x | 6.68x | 11.78x | 15.29x | 2,59 % | 210 Md | |
| 13.52x | 5.86x | -10.87x | 5.15x | 10.43x | 12.82x | 3,7 % | 210 Md | |
| -48.74x | 8.55x | 0.35x | 5.83x | 32.22x | 59.8x | 2,44 % | 168 Md | |
| 13.25x | 1.59x | 0.32x | 3.14x | 7.99x | 8.98x | 6,77 % | 145 Md | |
| 11.74x | 5.53x | 0.19x | 3.28x | 8.58x | 9.23x | 3,84 % | 135 Md | |
| 28.26x | 5.29x | 2.67x | 8.12x | 18.29x | 19.25x | -.--% | 121 Md | |
| 13.22x | 4.57x | 4.98x | 2.81x | 8.17x | 9.25x | 3,63 % | 103 Md | |
| 12.16x | 1.2x | -2.74x | 2.12x | 6.81x | 7.6x | 5,7 % | 103 Md | |
| 21.64x | 4.89x | 1.27x | 7.25x | 13.76x | 14.4x | 2,05 % | 69,76 Md | |
| 20.42x | 1.7x | -0.12x | 1.67x | 7.9x | 13.27x | 0,28 % | 54,59 Md | |
| 42.44x | 1.13x | 20.25x | 2.65x | 9.2x | 27.92x | 3,87 % | 53,57 Md | |
| 38.37x | 5.12x | 2.13x | 8.76x | 29.22x | 31.98x | 0,49 % | 52,24 Md | |
| 18.61x | 1.86x | 4.74x | 3.37x | 12.56x | 14.09x | 2,25 % | 42,37 Md | |
| Moyenne | 19,51x | 50,14x | 0,99x | 5,23x | 14,35x | 18,12x | 2,54 % | 220,71 Md | |
| Moyenne pondérée par Capi. | 22,87x | 95,53x | -0,31x | 6,87x | 16,64x | 19,19x | 2,29 % |
- Bourse
- Actions
- Action NBIX
- Secteur Neurocrine Biosciences, Inc.
- Valorisations sectorielles
🔇
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
